your badges 52W Range $11–$38 68% of range Analyst Rating BUY 12 analysts Price Target $48 +65% upside P/E · ROE · Net Profit Margin ·

SRZN Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $29.32
Market Cap (MRQ) $337M
52W Range $11–$38

SRZN Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

Stock splits 1
Ex-date Split Type
Dec. 14, 2023 1-for-15 Reverse

10-Year Performance Revenue, net income, margins and EPS trends

06
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric 5Y trend SRZN 5Y avg Peer Median Verdict
P/B (MRQ) -1.2 · · ·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14
Avg Surprise -443.9%
PeriodReportEPS ActualEPS EstSurprise
June 30, 2026 Aug 7, 2026 $-0.41 $-1.31 68.8%
March 31, 2026 May 8, 2026 $-11.65 $-1.11 -946.0%
Dec. 31, 2025 $-14.03 $-1.21 -1059.1%
Sept. 30, 2025 $-8.36 $-1.16 -622.1%
June 30, 2025 $2.55 $-1.13 325.2%
March 31, 2025 $-7.43 $-1.82 -308.1%
Dec. 31, 2024 $-9.10 $-1.37 -565.8%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
No annual filings for SRZN

We don't have SEC filings for this ticker yet.

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
No data for this statement

Not enough fundamentals data to build this statement yet.

Institutional owners (13F) 71 filers · $321.0M total · As of June 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 71
Value held $321.0M
New positions 27
Exited positions 15
Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
27 (+12 vs prior Q) 15 (+4 vs prior Q) 19 (+2 vs prior Q) 11 (-2 vs prior Q) +1.6M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
Column Group LLC $49,744,853 1,916,950 15.50% Shares
TCG Crossover Management, LLC $38,226,971 1,473,101 11.91% Shares
Boxer Capital Management, LLC $26,963,591 1,105,683 8.40% Shares
MILLENNIUM MANAGEMENT LLC $17,725,900 683,079 5.52% Shares
Point72 Asset Management, L.P. $17,237,858 664,272 5.37% Shares
Venrock Adviser, LLC $16,424,559 632,931 5.12% Shares
STEMPOINT CAPITAL LP $13,786,568 602,798 4.29% Shares
PERCEPTIVE ADVISORS LLC $13,078,411 503,985 4.07% Shares
Spruce Street Capital LP $11,211,438 432,040 3.49% Shares
BlackRock, Inc. $10,246,721 394,864 3.19% Shares
VANGUARD CAPITAL MANAGEMENT LLC $10,186,673 392,550 3.17% Shares
BRAIDWELL LP $10,140,040 390,753 3.16% Shares
Kalehua Capital Management LLC $9,995,369 385,178 3.11% Shares
Vestal Point Capital, LP $7,906,161 304,669 2.46% Shares
VANGUARD GROUP INC $7,214,734 319,236 2.25% Shares
5AM Venture Management, LLC $7,038,938 271,250 2.19% Shares
Vivo Capital, LLC $6,747,000 260,000 2.10% Shares
Balyasny Asset Management L.P. $5,320,579 205,032 1.66% Shares
GEODE CAPITAL MANAGEMENT, LLC $5,233,617 201,652 1.63% Shares
ACUTA CAPITAL PARTNERS, LLC $4,499,600 173,395 1.40% Shares
REGENTS OF THE UNIVERSITY OF CALIFORNIA $3,456,722 133,207 1.08% Shares
STATE STREET CORP $3,453,530 133,084 1.08% Shares
GOLDMAN SACHS GROUP INC $2,946,130 113,531 0.92% Shares
ADAGE CAPITAL PARTNERS GP, L.L.C. $2,300,545 88,653 0.72% Shares
Euclidean Capital LLC $2,275,711 87,696 0.71% Shares
TWO SIGMA INVESTMENTS, LP $1,845,538 71,119 0.57% Shares
NORTHERN TRUST CORP $1,650,654 63,609 0.51% Shares
VANGUARD FIDUCIARY TRUST CO $1,545,971 59,575 0.48% Shares
ArrowMark Colorado Holdings LLC $1,430,442 55,123 0.45% Shares
VANGUARD PORTFOLIO MANAGEMENT LLC $1,324,125 51,026 0.41% Shares
Eversept Partners, LP $1,239,813 47,777 0.39% Shares
Walleye Capital LLC $1,007,690 38,832 0.31% Shares
Ellsworth Advisors, LLC $855,977 39,283 0.27% Shares
BANK OF AMERICA CORP /DE/ $812,105 31,295 0.25% Shares
UBS Group AG $758,493 29,229 0.24% Shares
FRED ALGER MANAGEMENT, LLC $622,904 24,004 0.19% Shares
XTX Topco Ltd $436,687 16,828 0.14% Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $422,907 16,297 0.13% Shares
Bank of New York Mellon Corp $399,085 15,379 0.12% Shares
LMR Partners LLP $351,804 13,557 0.11% Shares
RENAISSANCE TECHNOLOGIES LLC $321,105 12,374 0.10% Shares
Alyeska Investment Group, L.P. $264,379 10,188 0.08% Shares
Fisher Asset Management, LLC $255,348 9,840 0.08% Shares
Nuveen, LLC $253,791 9,780 0.08% Shares
RHUMBLINE ADVISERS $210,965 8,130 0.07% Shares
BNP PARIBAS FINANCIAL MARKETS $208,353 8,029 0.06% Shares
DEUTSCHE BANK AG\ $189,487 7,302 0.06% Shares
MORGAN STANLEY $185,569 7,151 0.06% Shares
WELLS FARGO & COMPANY/MN $173,813 6,698 0.05% Shares
MetLife Investment Management, LLC $121,939 4,699 0.04% Shares

Show all 71 institutional owners →

Activists & 5%+ owners 2 positions

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
The Column Group III GP, LP, The Column Group III, LP, The Column Group III-A, LP, The Column Group Opportunity III, LP, The Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Tim Kutzkey, Peter Svennilson ×3 filings May 18, 2026 29.30% Amendment · SEC
Consonance Capital Management LP, Consonance Capman GP LLC, Consonance Life Sciences, LLC, Mitchell Blutt, Benny Soffer, Kevin Livingston ×2 filings Sept. 29, 2021 · Initial filing · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Company insiders 19 insiders · 5 officers · 9 directors

19
Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Craig C Parker Chief Executive Officer May 1, 2026 M 16,553 0 1 $-150,785
Andrew Pedrum Maleki Chief Financial Officer Nov. 12, 2025 A · 0 0 $0
Charles O Williams Chief Operating Officer May 1, 2026 M 16,571 0 2 $-98,976
Yang Li Exec. Vice President, Research May 1, 2026 M 17,216 0 2 $-75,010
Geertrui Vanhove Chief Medical Officer Aug. 12, 2021 A · 0 0 $0
Mace Rothenberg Director May 13, 2026 A · 0 0 $0
Mary Haak-Frendscho Director May 13, 2026 A · 0 0 $0
Anna Berkenblit Director May 13, 2026 A · 0 0 $0
David J Woodhouse Director May 13, 2026 A · 0 0 $0
Tim Kutzkey Director May 13, 2026 A 1,016,658 18 0 $5,984,632
Christopher Y Chai Director May 13, 2026 A · 0 0 $0
Eric Bjerkholt Director May 13, 2026 A · 0 0 $0
Mitchell J Blutt MD Director Nov. 23, 2020 A 410,000 0 0 $0
Benny Soffer · Aug. 11, 2021 A 1,885,000 0 0 $0
Kevin Harold Livingston · Aug. 11, 2021 A 1,885,000 0 0 $0
Consonance Life Sciences · Aug. 11, 2021 A 1,885,000 0 0 $0
Jennifer Jarrett · Aug. 11, 2021 D 30,000 0 0 $0
Christopher Haqq · Aug. 11, 2021 D 30,000 0 0 $0
Donald J Santel · Aug. 11, 2021 D 30,000 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 9 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
IWC · iShares Trust 0.03% 25,130 SH Sept. 11, 2026 Daily
VTWO · VANGUARD SCOTTSDALE FUNDS 0.01% 42,455 SH Aug. 19, 2026 Daily
VTWG · VANGUARD SCOTTSDALE FUNDS 0.01% 7,916 SH Aug. 19, 2026 Daily
IWO · iShares Trust 0.01% 68,962 SH Sept. 11, 2026 Daily
RSSL · Global X Funds 0.01% 3,522 NS July 31, 2026 N-PORT
IWM · iShares Trust 0.00% 186,400 SH Sept. 11, 2026 Daily
VXF · VANGUARD INDEX FUNDS 0.00% 102,939 SH Aug. 19, 2026 Daily
VTI · VANGUARD INDEX FUNDS 0.00% 282,365 SH Aug. 19, 2026 Daily
VTHR · VANGUARD SCOTTSDALE FUNDS 0.00% 655 SH Aug. 19, 2026 Daily

SRZN Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21
rating · 12 analysts BUY
Median target $52.00 +77.4%
4 33.3% Strong Buy
7 58.3% Buy
1 8.3% Hold
0 0.0% Sell
0 0.0% Strong Sell

12-Month Price Target

5 analysts · 2026-10-03

Mean target $48.40 +65.1%

← Below all targets Current price $29.32
Low$40.00 Mean$48.40 High$54.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
SRZN · · · · · ·
INDP $6M -0.1 · · -2820.8% ·
CCCC $185M -1.5 1.0% -292.1% -48.8% ·
FENC $263M -22.6 -6.1% -21.8% -69.6% ·
ZNTL $93M -0.7 · · -49.5% ·
OCGN $422M -5.6 8.8% -1537.4% 1488.8% ·
CABA $220M -1.0 · · -115.5% ·
ARTV · -1.3 -99.2% · · ·
CYPH $97M 16.6 · · 6.1% ·
EBS $644M 13.3 -28.8% 7.1% 9.9% ·
SCTX · · · · · ·

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 10-Q filed May 6, 2026